A phase-II, randomized, placebo-controlled trial of simvastatin in generalized vitiligo
Principle Investigator: John E. Harris, MD, PhD
Study Location: UMass Memorial Medical Center in Worcester, MA
A research trial at UMass is studying whether simvastatin, a common cholesterol medication, is useful in treating vitiligo. The study includes taking either this medication or a placebo and visiting UMass 8 times over a period of 6-7 months. You will be compensated for your time and receive free parking.
You may be eligible if you are a patient with vitiligo and are:
• A male between 18 – 64 years of age
• Not currently taking a statin medication for heart disease
If you are interested in participating or would like more detailed information:
Call: (508) 856-2800 or Email: UMassVitiligoStudy@gmail.com